Similarly, in different immunophenotypes, such as GCB, Non-GCB, BCL-2 and BCL-6 positive groups, different levels of albumin could affect the prognosis of DLBCL patients. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.